Methods are provided for inhibiting stenosis following vascular trauma or disease in a mammalian host, comprising administering to the host a therapeutically effective dosage of a therapeutic conjugate containing a vascular smooth muscle binding protein that associates in a specific manner with a cell surface of the vascular smooth muscle cell,...
Cabazitaxel 890654-44-1 Bufexamac Bufexamac HDAC Inhibitors
没有评论:
发表评论